CSTONE PHARMA-B

02616

----

H1 2026 Earnings

Financial report interval: 2025.12.30 - 2026.06.30

Overview: CSTONE PHARMA-B(02616) the Revenue is 236.9 M (+337.2%), Beat estimate;the EBIT is -272.32 M (+10.33%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.24B337.19%

0.16B192.00%

+0.08B145.19%

EBITExceed expectations

-0.27B10.33%

-0.31B3.23%

+0.04B13.56%

Revenue

ActualEstimateUnit: HKD

Quarterly

EBIT

ActualEstimateUnit: HKD

Quarterly

Net income

ActualEstimateUnit: HKD

Quarterly

EPS

ActualEstimateUnit: HKD

Quarterly